Trial Review

Registering a new trial?

To achieve prospective registration, we recommend submitting your trial for registration at the same time as ethics submission.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial details imported from ClinicalTrials.gov

For full trial details, please see the original record at https://clinicaltrials.gov/study/NCT00282269




Registration number
NCT00282269
Ethics application status
Date submitted
25/01/2006
Date registered
26/01/2006
Date last updated
22/06/2010

Titles & IDs
Public title
Hypothermia in Traumatic Brain Injury in Children (HiTBIC)
Scientific title
Pilot Study of Early and Prolonged Hypothermia in Severe Traumatic Brain Injury in Children
Secondary ID [1] 0 0
NTX/06/02/002
Universal Trial Number (UTN)
Trial acronym
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Traumatic Brain Injury 0 0
Condition category
Condition code
Injuries and Accidents 0 0 0 0
Other injuries and accidents
Neurological 0 0 0 0
Other neurological disorders
Skin 0 0 0 0
Other skin conditions

Intervention/exposure
Study type
Interventional
Description of intervention(s) / exposure
Treatment: Surgery - Induced Hypothermia

Treatment: Surgery: Induced Hypothermia
Induced Hypothermia within 6 hours of injury and maintained for a minimum of 72 hours
Intervention code [1] 0 0
Treatment: Surgery
Comparator / control treatment
Control group

Outcomes
Primary outcome [1] 0 0
Paediatric Cerebral Performance Category (PCPC) at 12 months after injury
Timepoint [1] 0 0
12 months
Primary outcome [2] 0 0
Recruitment Rates
Timepoint [2] 0 0
Recruitment completion
Primary outcome [3] 0 0
Adverse Events
Timepoint [3] 0 0
Recruitment completion
Secondary outcome [1] 0 0
Intracranial pressure(ICP)/Cerebral perfusion pressure(CPP) control
Timepoint [1] 0 0
Recruitment completion
Secondary outcome [2] 0 0
Duration of mechanical ventilation
Timepoint [2] 0 0
Recruitment completion
Secondary outcome [3] 0 0
Intensive care and hospital length of stay
Timepoint [3] 0 0
Recruitment completion
Secondary outcome [4] 0 0
Neuropsychological Outcome
Timepoint [4] 0 0
12 months

Eligibility
Key inclusion criteria
* have a severe traumatic brain injury as defined by either a GCS = 8 and an abnormal CT scan (intracranial hemorrhage, cerebral edema or diffuse axonal injury) or a motor score = 3 and normal CT scan
* are aged between 1 and 16 years
* are mechanically ventilated
Minimum age
1 Year
Maximum age
16 Years
Sex
Both males and females
Can healthy volunteers participate?
No
Key exclusion criteria
* are not randomized by 6 hours after injury
* have penetrating brain injuries
* have fixed dilated pupils and GCS = 3
* have proven cervical spinal cord injury
* have more than mild neurodevelopmental disability prior to injury
* have an acute isolated epidural hematoma and are expected to recover rapidly after surgical removal
* have had a post-traumatic seizure with a normal CT scan
* have refractory shock, defined as systolic blood pressure more than 2 standard deviations (SD) below the mean for age despite 80ml/kg intravenous fluid resuscitation

Study design
Purpose of the study
Treatment
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Masking / blinding
Blinded (masking used)
Who is / are masked / blinded?


The people assessing the outcomes
Intervention assignment
Single group
Other design features
Phase
Phase 2
Type of endpoint/s
Statistical methods / analysis

Recruitment
Recruitment status
Completed
Data analysis
Reason for early stopping/withdrawal
Other reasons
Date of first participant enrolment
Anticipated
Actual
1/11/2006
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
1/06/2010
Sample size
Target
50
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
NSW,QLD,SA,VIC,WA
Recruitment hospital [1] 0 0
Royal Alexandra Hospital for Children - Sydney
Recruitment hospital [2] 0 0
Sydney Children's Hospital - Sydney
Recruitment hospital [3] 0 0
Queensland Paediatric Intensive Care Services - Brisbane
Recruitment hospital [4] 0 0
Women's and Children's Hospital - Adelaide
Recruitment hospital [5] 0 0
Royal Children's Hospital - Melbourne
Recruitment hospital [6] 0 0
Princess Margaret Hospital - Perth
Recruitment postcode(s) [1] 0 0
- Sydney
Recruitment postcode(s) [2] 0 0
- Brisbane
Recruitment postcode(s) [3] 0 0
- Adelaide
Recruitment postcode(s) [4] 0 0
- Melbourne
Recruitment postcode(s) [5] 0 0
- Perth
Recruitment outside Australia
Country [1] 0 0
New Zealand
State/province [1] 0 0
Auckland

Funding & Sponsors
Primary sponsor type
Other
Name
Australia and New Zealand Intensive Care Society
Address
Country

Ethics approval
Ethics application status

Summary
Brief summary
The purpose of this study is:

* To determine the safety and feasibility of performing an international multi-centre randomized control trial of early and prolonged hypothermia to improve outcome in children with severe traumatic brain injury (TBI).
* To determine whether in children with severe traumatic brain injury, prolonged initial hypothermia (minimum 72 hours at 32-33 degrees) improves the proportion of good outcomes 12 months after injury when compared to initial normothermia (36-37 degrees).
Trial website
https://clinicaltrials.gov/study/NCT00282269
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 0 0
John Beca, FJFICM
Address 0 0
Starship Children's Hospital, Auckland, New Zealand
Country 0 0
Phone 0 0
Fax 0 0
Email 0 0
Contact person for public queries
Name 0 0
Address 0 0
Country 0 0
Phone 0 0
Fax 0 0
Email 0 0
Contact person for scientific queries



Summary Results

For IPD and results data, please see https://clinicaltrials.gov/study/NCT00282269